新型抗肿瘤药物Epothilones的电子结构研究

摘要采用量子化学和分子力学方法寻找一类新型促微管蛋白聚合的大环内酯类抗肿瘤药(Epothilones)的优势构象并进行定量构效关系的研究。通过相关性分析得知,分子的偶极矩和核-核排斥能对分子的活性差异性有显著的影响,可以通过改变C12和C15侧链来改变分子的偶极矩从而提高Epothilones的生物活性。此外,C7上的O原子和C15侧链噻唑基团上的N原子的负电荷增加,对Epothilones的生物活性的增大有利。

	Service

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	Email Alert
	RSS
	作者相关文章
	栾林波
	李艳妮

关键词：大环内酯抗肿瘤药(Epothilones) 定量构效关系(QSAR)

Abstract： Epothilones are a class of novel microtubule stabilizing agents.By quantum chemistry and molecular mechanics methods,the quantitative structure-activity relationship(QSAR) research was conducted after the optimized conformations were found.It is important for increasing the bioactivities of epothilones to revise the structure at C12 and C15 sidechain to change their dipole moment and nuclear repulsive potentials.In addition,it is favorable to increase the negative charge of O at C7 and N at thiazole in C15 sidechain for increasing the bioactivities of epothilones.

Keywords：

Received 2007-03-15; published 2007-03-15

引用本文:

栾林波;李艳妮;.新型抗肿瘤药物Epothilones的电子结构研究[J]. 化学工业与工程, 2007,24(2): 112-116

LUAN Lin-bo,LI Yan-ni.Electronic Structure of a Novel Anti-Tumor Drug of Epothilones[J]. Chemcial Industry and Engineering, 2007,24(2): 112-116

[1]	GERTH K,BEDORF N,HOFLE G,et al.Epothilones Aand B:Antifungal and cytotoxic compounds from sorangiumcellulosum(myxobacteria)-production,physico-chemicaland biological properties[J].J Antibiotics,1997,49:560-563.
[2]	ROWINSKY E K.The development and clinical utility ofthe taxane class of antimicrotubule chemotherapy agents[J].Annu Rev Med.1997,48:353-374
[3]	HERBERT,ROLF,KLAUS,et al.Chivosazol A,a newinhibitor of eukaryotic organisms isolated from myxobacteria[J].J Antibiotics,1995,48:962-966.
[4]	ALTMANN K H,MARKUS W,TERENCE O R.Epothilones and related structures:A new class ofmicrotubule inhibitors with potent in vivo antitumor activity[J].Biochimica et Biophysica Acta,2000,3:M79-M91.
[5]	HOFLE G,BEDORF N,STEINMETZ H,et al.Epothilone A and B-novel 16-membered macrolides withcytotoxic activity:Isolation,crystal structure andconformation in solution[J].Angew Chem Int Ed Engl,1996,35:1 567-1 569.
[6]	CHOU Ting-chao,ZHANG Xiu-guo,CHRISTINA R,etal.Desoxyepothilone B is curative against human tumorxenografts that are refractory to paclitaxel[J].PNAS,1998,95:15 798-15 802.
[7]	BOLLAG D M,MCQUENEY P A,ZHU J,et al.Epothilones,a new class of microtubule-stablizing agentswith a taxol-like mechanism of action[J].Cancer Res,1995,55:2 325-2 333.
[8]	DIRK W H,SCHUBERT W D,HOLFE G.Muchanticipated-the bioactive conformation of epothilone and itsbinding to tubulin[J].Angew Chem Int Ed.2005,44:1-
[9]	KEUN W L,JAMES M B.Comparative molecular fieldanalysis(CoMFA)study of epothilones-tubulindepolymerization inhibitors:Pharmacophore developmentusing 3D-QSAR methods[J].JCMAD,2001,15:41-55.
[10]	ANNALEN B,JENS M.Epothilones:Quantitative structureactivity relations studied by support vector machines andartificial neural networks[J].QSAR Comb Sc.2003,22:722-728
[11]	JAMES H,NETTLES,LI Huilin,et al.The binding modeof epothilone A onα,-tβubulin by electron crystallography[J].Science.2004,305:866-869
[12]	NICOLAOU K C,FRANK R,DIONISIOS V.Chemicalbiology of epothilones[J].Angew Chem Int Ed,1998,37:2 014-2 045.
[13]	NICOLAOU K C,RAY M,FINLAY V,et al.Synthesisand biological properties of Cl 2,13-cyclopropyl-epothiloneA and related epothilones[J].Chemistry&Biology.1998,5:365-372
[14]	NICOLAOU K C,SCARPELLI R,BOLLBUCK B,et al.Chemical synthesis and biological properties of pyridineepothilones[J].Chemistry&Biology.2000,139:283-299
[15]	RANNAR S,GELADI P,LINDGREN F.The kernelalgorithm for PLS,ⅡFew observations and manyvariables[J]..Journal of Chemometrics.1994,8:111-125